megamillionsjackpotlotterynumbers| Shanghai Laishi: Zhengzhou Laishi adjusted the R & D project based on the consideration of pulp mining scale, production scale and market demand

Some investors ask questions on the investor interactive platformmegamillionsjackpotlotterynumbers: 1. According to the annual reportmegamillionsjackpotlotterynumbersAt present, R & D investment is underway. The innovative drug at home and abroad is SR604 injection, and there is also a domestic innovative drug that activates prothrombin complex. I would like to ask if there are other innovative drugs under development? Or early preparation of plans for research. 2. According to the annual report, the Zhengzhou Laishi human coagulation factor VIII and human prothrombin complex project has been terminated in early 2024. I would like to ask what were the reasons for the termination of research and development of two R & D projects.

Shanghai Lai Shi (002252megamillionsjackpotlotterynumbers.SZ) stated on the investor interactive platform on May 14, 1. You can refer to the relevant chapters of the 2023 annual report for the overall research and development of the company. 2. Zhengzhou Laishi adjusted the R & D project based on the consideration of pulp mining scale, production scale and market demand.

(Article source: Daily Economic News)

Tags:

Prev: totalcasinobonus20freespins2022| Dow Technology: The company has a good layout in the field of solid-state batteries and downstream manufacturers that have sent samples such as carbon nanotube conductive agents
Next: crashbandicoot4price| 6 virtual asset ETFs: turnover was HK$17.2903 million, down 30.53% from the previous day